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Abstract
Background: Nausea and vomiting during pregnancy (NVP) affects two-thirds of pregnant women
to varying degrees and over the years many modalities have been used to try to alleviate this often
debilitating condition. There is a paucity of information in the literature about the use or efficacy
of complementary and alternative medicine (CAM) for the treatment of this condition that affects
so many women. Our primary objective was to examine the prevalence of CAM usage by women
suffering from NVP. Our secondary objective was to ascertain if women had any supervision in the
use of these treatments.
Methods: Women who called The Motherisk NVP helpline, were asked after the counseling
session to complete a questionnaire, which included demographic data as well as information about
their CAM use.
Results: Seventy women completed the questionnaire. 61% reported using CAM therapies, of
which the three most popular were: ginger, vitamin B6 and acupressure. 21% of those who
reported using CAM, had consulted CAM practitioners, 8% their physicians or pharmacists and
71% discussed the usage with family, friends and other allied health professionals. Women who did
not use CAM stated they would probably use these modalities if there was more information about
the safety in pregnancy.
Conclusion: Pregnant women with NVP are mirroring the trend in the general population of the
use of CAM. They are also using CAM therapies with little supervision from practitioners
experienced in the use of these modalities.
Introduction
Nausea and vomiting during pregnancy (NVP) affects up
to 80 % of all pregnant women, and has a significant im-
pact on the quality of life of those who experience it [1,2].
The effects can range from mild nausea to more severe
forms such as hyperemesis gravidarum, which is character-
ized by an intractable nausea and vomiting so severe that
it can lead to hospitalization. Although only 0.3 to 3% of
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pregnant women are diagnosed with hyperemesis gravi-
darum[3], less severe forms of NVP exert a significant im-
pact on the quality of life of those affected [1]. In one
study, close to 50% of employed women reported reduced
work efficiency due to NVP, with as many as 25–66% of
women actually requiring time off work. Furthermore, al-
most 50% of women reported that their NVP negatively
affected their relationship with their partner as well as
having an adverse effect on their partner's day-to-day life
[4].
There are a number of effective options available for the
alleviation of NVP, varying from non-pharmacological
strategies such as diet and lifestyle changes to pharmaco-
logical treatments such as Diclectin® (doxylamine/pyri-
doxine) [5], antihistamine H1 blockers [6],
phenothiazines [7], as well as pyroxidine (vitamin B6)
alone [3,8]. The thalidomide tragedy of the 1960's as well
as the Bendectin® unfounded scare of the mid 1980's
[9,10] has caused women with NVP to look on drug-based
strategies with great caution due to concerns over the per-
ceived teratogenicity of these drugs [4,11], even when data
exist documenting safety [5,9,10]. Accordingly, non-phar-
macological strategies to alleviate NVP may be popular
choices amongst pregnant women. In addition to dietary
and lifestyle changes, the use of (CAM) to alleviate NVP
may be an attractive option for many women. The per-
ceived "natural" status of herbal products in particular
and CAM in general lead many to draw the conclusion
that CAM therapies are not associated with adverse effects.
The use of CAM has increased rapidly in the last decade
[12,13]. Estimates of the prevalence of CAM use in the
United States were as high as 42% in 1997, with CAM use
particularly popular among women of reproductive age
[12,13]. In addition, almost half of women surveyed re-
ported using CAM (48.2%) [12]. Consequently, the possi-
bility that pregnant women are using CAM to alleviate
complaints such as NVP is quite possible, although the ex-
act percentage remains unknown. The use of CAM thera-
pies among pregnant women is an important but little
studied issue. One study assessing the CAM prescribing
patterns of Nurse-Midwives in North Carolina revealed
that almost half of nurse-midwives surveyed recommend-
ed CAM therapies to more than 10% of their patients[14].
Another study of women attending antepartum visits re-
vealed that almost 10% of these women reported using
herbal supplements during their pregnancy, with 7.5% of
these women using these preparations on a weekly basis
[15]. Furthermore, 13.5% of these women reported using
other non-herbal CAM therapies. There are a handful of
studies suggesting effective relief of NVP by CAM thera-
pies such as ginger [3,16], manual acupuncture [17,18],
acupressure [3] and vitamin B6 [3,8]. Nevertheless, there
is little research on the efficacy and safety of the full range
of CAM modalities used by women to alleviate NVP. Fur-
thermore, there is little information about the types of
CAM treatments that are being used by women experienc-
ing NVP, as well as how they obtain information about
potential CAM therapies Finally, the degree of supervision
of CAM use in this population is not well defined.
This pilot study was undertaken to investigate the preva-
lence, supervision and types of CAM treatments used for
NVP by women using the NVP counseling line at the
Motherisk Program located at the Hospital for Sick Chil-
dren in Toronto, Ontario.
Patients and methods
Women receiving counseling by the Motherisk Program
NVP line, who call us from across North America, were
asked whether or not they wished to complete a phone
survey regarding their use or non-use of CAM to alleviate
their NVP. The questionnaire was administered to the sur-
vey participants either directly following the counseling
session or at a later time mutually agreed upon by the par-
ticipant and the interviewer.
Demographic data were collected for all of the survey re-
spondents including the number of previous children,
previous experience with NVP, pregnancy-related medica-
tion as well as any adverse experiences related to pregnan-
cy-related medication. In addition, all respondents were
asked to describe the severity of their NVP on a scale of 0–
10, with 10 being the most severe, as well as whether or
not they had previously used CAM. Survey respondents
who reported non-use of CAM to alleviate NVP were
asked to agree or disagree with a series of possible reasons
why they did not use CAM to alleviate their NVP. The level
of agreement was measured by a 5-point Likert Scale,
where 1 = strongly disagree, 2 = disagree somewhat, 3 =
undecided, 4 = somewhat agree and 5 = strongly agree. Re-
spondents who reported using CAM to alleviate their NVP
were asked which CAM therapies they had used. They
were also asked how they found out about CAM therapies,
and whether or not their CAM use was supervised by a li-
censed health care practitioner who practiced CAM either
as part of their practice or in whole. Users of CAM were
also asked 9 possible reasons why they chose to use CAM
to alleviate their NVP, using the same Likert Scale used for
non-CAM users.
The demographic data, reported severity of NVP, and pre-
vious CAM use were compared between users and non-us-
ers of CAM. The level of agreement with statements
regarding CAM use or non-use was reported as a mean
Likert Scale value plus standard deviation. Simple numer-
ical analysis was used to report the types of CAM interven-
tions used as well as the numbers and types ofBMC Complementary and Alternative Medicine 2002, 2 http://www.biomedcentral.com/1472-6882/2/5
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practitioners consulted and source used to access CAM in-
formation.
Results
A total of seventy out of 110 women consented to be in-
terviewed and completed the questionnaire. 10 women
refused to participate and 30 were lost to follow up. The
demographics of the women lost to follow up did not dif-
fer significantly from the respondents. Demographic char-
acteristics of the questionnaire respondents are
summarized in Table 1. Almost half of the respondents
were between the ages of 30–34. In addition, the majority
were married (or living with a partner), Caucasian, had
completed a college, university or post-graduate degree
and reported a total household income of $41,000 (CDN)
/ year or greater. Almost half were employed full-time and
one-third identified themselves as homemakers. Most sur-
vey respondents indicated that they had one child or less
at time of interview and two-thirds reported having expe-
rienced nausea and vomiting in a previous pregnancy.
Half of the respondents reported using pharmaceutical
drugs during their pregnancy, with Diclectin® being the
most commonly used medication (used by two-thirds of
those who indicated that they had taken medication).
More than half of all Diclectin® users reported an adverse
effect from the drug, namely drowsiness, with three wom-
en also reporting irritability and dry mouth. Most of the
respondents reported that their family physician or obste-
trician was their primary obstetric caregiver at the time of
the interview.
Almost two-thirds (61.2%) of the survey respondents re-
ported using CAM to alleviate NVP. The three most com-
mon types of CAM used are summarized in Table 2 and
were: ginger teas or tablets, accupressure / seabands, and
Vitamin B6). The most common information sources for
respondents about the use of CAM for NVP are also sum-
marized in Table 2 and were: family and friends, women's
health centres, or pregnancy counseling lines, CAM prac-
titioners followed by their doctor or pharmacist. The most
commonly consulted CAM practitioners were acupunc-
turists, chiropractors, homeopaths and naturopaths. Only
21.6 % of respondents consulted with a CAM practitioner
when using CAM to alleviate NVP. Furthermore, 20.7 % of
CAM users reported mild adverse reactions associated
with using CAM to alleviate their NVP. The most com-
monly reported adverse experiences were the intolerabili-
ty of the strong flavour of ginger and wrist irritation
among respondents who used acupressure wrist bands.
Survey respondents were asked why they chose to use
CAM to alleviate their NVP (table 3) and were also asked
why they did not use CAM (table 4). The most common
reason given for using CAM was: because this was not re-
Table 1: Demographic Characteristics of Survey Respondents
No. Percent Total No. of 
Respondents
Age
20–24 3
25–29 16 22.9
30–34 34 48.6
35–39 16 22.9
40–45 1 1.4
70
Declared Ethnicity
Caucasian 60 87.0 70
Latin American 3 4.3
Black 3 4.3
Other 3 4.3
69
Marital/Civil Status
Single 2 2.9
Married/ Living with Partner 62 88.6
Separated / Divorced 1 1.4
65
Highest Level of Education
public school 3 4.7
high school 10 15.6
college / university 43 67.2
post-graduate training 8 12.5
64
Previous Number of Children
0 21 30.9
1 28 41.2
2 13 19.1
3 6 8.8
68
Total Household Income
< $10,000 / yr. 2 3.3
$10, 000 – < $20,000 3 5.0
$20,000 – < $30,000 6 10.0
$30,000 – < $40, 000 6 10.0
$40,000 – < $50,000 8 13.3
greater than $50,000 35 58.3 60
Type of Employment
unemployed 1 2.7
part-time 5 13.9
full time 16 44.4
student 1 2.7
homemaker 13 36.1 36
Previous NVP Experience
No 17 32.7
Yes 35 67.3 57
Obstetric Care
None 5 7.8
Family physician 37 57.8
Midwife 6 9.4
Nurse practitioner 0 0.0
Obstetrician 10 15.6 64BMC Complementary and Alternative Medicine 2002, 2 http://www.biomedcentral.com/1472-6882/2/5
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ally a "drug" and it was probably safer to use in pregnancy
than a pharmaceutical product. The most common reason
for not using CAM was: there was not enough information
about the use of these products.
The level of education, income, severity of NVP, and pre-
vious CAM use were assessed as possible predictors of
CAM use in survey respondents. Out of these four factors
assessed, only NVP severity was associated with CAM us-
age to alleviate NVP: Table 5
Discussion
This study was undertaken to investigate the prevalence,
types of CAM treatments used and supervision if any, of
Table 2: Common CAM Treatments, Practitoners and Informa-
tion Sources Used for NVP
The Most Common CAM treatments 
used for NVP * %
1. ginger teas or tablets 50.7
2. accupressure/seabands 45.8
3. Vitamin B6 29.2
The Most Common Sources Used for Obtaining Information 
About CAM
1. Friends/family 40.1
2. Allied health professionals 30.3
3. CAM practitioners 21.6
4. Doctor / Pharmacist 8.1
The Most Commonly Consulted CAM Practitioners
1. acupuncturists 63.6
2. chiropractors 18.2
3. naturopaths 10
4. homeopaths 9.1
*Some women used more than one
Table 3: Common Reasons Respondents Chose CAM to Alleviate 
NVP.*
Most Common Reasons Mean+SD
I do not like to use drugs unless it is neces-
sary
4.52 ± .78
I did not want to use drugs for fear of harm-
ing my baby
4.20 ± 1.2
I wanted to be more in control of my health 
care decisions
4.12 ± 1.0
Least Common Reasons
I was prescribed medicines for my NVP which 
gave me side effects
2.1 ± 1.2
* 1 = strongly disagree, 2 = somewhat disagree, 3 = undecided, 4 = 
somewhat agree, 5 = strongly agree
Table 4: Common Reasons Respondents did not Choose CAM to 
Alleviate NVP.*
Reasons Most Agreed Upon Mean+SD
I would feel more comfortable in using CAM 
if I had access to someone who is knowledge-
able about its use
4.0 ± .98
I would like more information about CAM 
before I use it
3.97 ± 1.1
Reasons Least Agreed Upon
I have had some bad experiences with CAM 
in the past
1.7 ± .59
I have had some bad experiences with CAM 
practitioners in the past
1.7 ± .84
CAM use is against my religion 1.5 ± .82
* 1 = strongly disagree, 2 = somewhat disagree, 3 = undecided, 4 = 
somewhat agree, 5 = strongly agree
Table 5: Possible predictors of CAM use in Women Suffering 
From NVP (n = 58)
Predictor Chi square Two-sided p-value
Level of Education 0.061 .804
Income 0.055 .815
Previous CAM use 1.662 .197
Severity of NVP 6.801 0.009
"Severity" here is defined as experiencing nausea and vomiting greater 
than three times / dayBMC Complementary and Alternative Medicine 2002, 2 http://www.biomedcentral.com/1472-6882/2/5
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the treatment of nausea and vomiting of pregnancy by
women using the NVP counseling line at the Motherisk
Program at the Hospital for Sick Children in Toronto, On-
tario, Canada. Because the use of CAM has become more
prevalent in the general population in recent years, cou-
pled with the fact that 70% of all pregnant women suffer
from NVP, one might be able to extrapolate these results
to the general population of women who suffer from
NVP, but did not call the NVP helpline. It is a fact that
women who call the NVP helpline do have a higher SES
status and it is known that SES status has an impact on the
use CAM.(19) However, there was no correlation between
the use of CAM and higher SES in our study, the only fac-
tor that predicted the use of CAM was the severity of NVP.
This finding may appear to be suprising, however it was
not to us at the Motherisk NVP Helpline, because over the
years, many women have told us that NVP can be so de-
bilitating that they will try just about anything to alleviate
their symptoms.
Our results showed that CAM was used by almost two-
thirds of our surveyed population of women experiencing
NVP. Even the women who did not use CAM felt they
would have if there was more information on the safety
during pregnancy. We also found that CAM use in this
population is largely unsupervised, with most women get-
ting information from their family and friends and buying
the products directly from herbal stores. Women who
used CAM reported that it made them feel more in control
of their health care decisions and that they perceived it
would be safer than pharmaceutical products.
The population at large has probably been exposed to the
use of CAM through media, such as television and maga-
zines as well as the internet, which is present in almost
half of the homes in the country and may feel that because
of this they are knowledgable about this form of medi-
cine. Many people today feel that they would like to be
more in control of their own health care and perceive that
CAM allows this, as neither a prescription nor physician
visit is required for the use of these treatments.
Natural is often perceived as "safe" which is not necessar-
ily always the case. This perception can be especially true
with pregnant women, who wish to protect their fetuses
from "harmful things" such as pharmaceutical products.
This is born out by the fact that many women call our gen-
eral Motherisk Program information line asking about the
safety of other CAM use during pregnancy, as they feel this
would be a safer option for their baby. The number of
calls about the use of CAM in general during pregnancy
has increased dramatically over the past few years reflect-
ing the population's interest in this form of treatment.
Unfortunately, we have to inform the callers that there is
scant research on the use and safety of CAM during preg-
nancy, whereas there are quite a substantial number of
studies in the current literature regarding the use and safe-
ty of pharmaceutical products during pregnancy.
The limitation of this study is primarily the small sample
size, as seventy women are a low number for a survey of
this kind. It is also not a population based study as wom-
en who call our helpline do differ in some ways from the
general population.
In summary, a significant amount of women are using
CAM in pregnancy for the treatment of NVP, despite the
lack of safety or efficacy data and often without any super-
vision from a knowledgable practitioner. Further research
in this field may allow pregnant women more options in
treating this very common conditon of pregnancy.
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